Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review

BACKGROUND: Progression-free survival (PFS) is a surrogate endpoint widely used for overall survival (OS) in oncology. Validation of PFS as a surrogate must be done for each indication and each intervention. We aimed to identify all studies evaluating the validity of PFS as a surrogate for OS in onc...

Descripción completa

Detalles Bibliográficos
Autores principales: Belin, Lisa, Tan, Aidan, De Rycke, Yann, Dechartres, Agnès
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250908/
https://www.ncbi.nlm.nih.gov/pubmed/32214230
http://dx.doi.org/10.1038/s41416-020-0805-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250908/
https://www.ncbi.nlm.nih.gov/pubmed/32214230
http://dx.doi.org/10.1038/s41416-020-0805-y

Ejemplares similares